Thursday, July 2, 2009
|
Alcon Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction
HSMN NewsFeed,
2 Jul 2009:
Biopharmaceuticals, Ophthalmology
[Alcon, anecortave, intraocular pressure, glaucoma]
|
Nephros Receives 510k Approval for Dual Stage Ultrafilters
HSMN NewsFeed,
2 Jul 2009:
Devices, FDA
[Nephros, Dual Stage Ultrafilter, dialysis]
|
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
HSMN NewsFeed,
2 Jul 2009:
Biopharmaceuticals, Cardiology, FDA
[sanofi-aventis, Multaq, dronedarone, atrial fibrillation, atrial flutter]
|
CombinatoRx and Neuromed Sign Merger Agreement
HSMN NewsFeed,
2 Jul 2009:
Biopharmaceuticals, Mergers & Acquisitions, Personnel
[Neuromed Pharmaceuticals, CombinatoRx]
|
Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)
HSMN NewsFeed,
2 Jul 2009:
Biopharmaceuticals, FDA
[King Pharmaceuticals, Acura Pharmaceuticals, Acurox, oxycodone]
|
RaySearch Wins Breakthrough Order for Proton Treatment Planning System
HSMN NewsFeed,
2 Jul 2009:
Devices, Oncology
[RaySearch Laboratories, proton therapy, proton beam, radiotherapy]
|
Applied Spine Technologies to Restart U.S. Clinical Trial for Stabilimax NZ(R) Dynamic Spine Stabilization System
HSMN NewsFeed,
1 Jul 2009:
Devices, Orthopaedic, Neurosurgery, FDA
[Applied Spine Technologies, Stabilimax NZ, Spine Stabilization]
|
Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment
HSMN NewsFeed,
1 Jul 2009:
Biopharmaceuticals
[Shire plc, VYVANSE, lisdexamfetamine, ADHD]
|
Eisai and Pfizer Decide not to Appeal NICE Decision and Call for an Expedited Review of Guidance for Alzheimer's Disease
HSMN NewsFeed,
1 Jul 2009:
Biopharmaceuticals, Neurology
[Eisai, Pfizer, Aricept, donepezil, Alzheimer's disease]
|
Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
HSMN NewsFeed,
1 Jul 2009:
Biopharmaceuticals, Oncology
[Morphotek, Eisai, Synageva BioPharma, monoclonal antibody, farletuzumab]
|
Myriad Pharmaceuticals, Inc. Established as an Independent Pharmaceutical Development Company
HSMN NewsFeed,
1 Jul 2009:
Biopharmaceuticals
[Myriad Pharmaceuticals, Myriad Genetics]
|
LabCorp Commences Cash Tender Offer for All Outstanding Shares of Monogram Biosciences, Inc.
HSMN NewsFeed,
1 Jul 2009:
Diagnostics, Mergers & Acquisitions
[Laboratory Corporation of America, Monogram Biosciences]
|
ArthroCare Names Andrew Miclot Senior Vice President, General Manager of ENT Business
HSMN NewsFeed,
1 Jul 2009:
Devices, Personnel
[ArthroCare]
|
Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S.
HSMN NewsFeed,
1 Jul 2009:
Biopharmaceuticals, Neurology, Licensing
[Acorda Therapeutics, Biogen Idec, Fampridine-SR, multiple sclerosis]
|
Teva Announces Approval and Launch of Tri-Lo Sprintec Tablets
HSMN NewsFeed,
1 Jul 2009:
Biopharmaceuticals, Generics, FDA
[Teva Pharmaceutical, Ortho McNeil Janssen, Ortho Tri-Cyclen Lo, Tri-Lo Sprintec]
|
MMDI Announces Agreement with Novation to Supply the Rebound HRD(R)
HSMN NewsFeed,
30 Jun 2009:
Devices, Surgery, Group Purchasing
[MMDI, Novation, Rebound HRD, hernia repair device]
|
FDA Approves Feraheme to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients
HSMN NewsFeed,
30 Jun 2009:
Biopharmaceuticals, FDA
[AMAG Pharmaceuticals, Feraheme, ferumoxytol]
|
Small Bone Innovations, Inc. Raises $144 Million
HSMN NewsFeed,
30 Jun 2009:
Devices, Orthopaedic, Venture Capital
[Small Bone Innovations]
|
Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices Agreement
HSMN NewsFeed,
30 Jun 2009:
Biopharmaceuticals, Group Purchasing
[Hospira, MedAssets]
|
Study Finds Edwards Lifesciences' Port Access System Facilitates Improved Outcomes Compared to Sternotomy
HSMN NewsFeed,
30 Jun 2009:
Devices, Cardiology
[Edwards Lifesciences, PORT ACCESS System, mitral valve repair]
|
Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
HSMN NewsFeed,
30 Jun 2009:
Biopharmaceuticals
[Catalyst Biosciences, Wyeth Pharmaceuticals, Factor VIIa, hemophilia]
|
Gore Receives FDA Approval for Modification of GORE VIABAHN® Endoprosthesis
HSMN NewsFeed,
30 Jun 2009:
Devices, Interventional, FDA
[W. L. Gore, GORE VIABAHN, Endoprosthesis]
|
Hyperion Therapeutics Raises $60 Million Series C
HSMN NewsFeed,
30 Jun 2009:
Biopharmaceuticals, Venture Capital
[Hyperion Therapeutics]
|
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
HSMN NewsFeed,
30 Jun 2009:
Biopharmaceuticals, Mergers & Acquisitions
[Cell Genesys, BioSante Pharmaceuticals, LibiGel]
|
Tryton Announces First Patient Enrollment in E-Tryton 150 Registry
HSMN NewsFeed,
30 Jun 2009:
Devices, Interventional Cardiology
[Tryton Medical, E-Tryton 150, Side Branch Stent, bifurcation]
|
DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation
HSMN NewsFeed,
29 Jun 2009:
Biopharmaceuticals
[DOR BioPharma, orBec , beclomethasone, GI GVHD]
|
Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer
HSMN NewsFeed,
29 Jun 2009:
Biopharmaceuticals, Personnel
[Horizon Therapeutics]
|
Teva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin(R) (Human Growth Hormone)
HSMN NewsFeed,
29 Jun 2009:
Biopharmaceuticals, Drug Delivery, FDA
[Teva Pharmaceutical, Antares Pharma, Tev-Tropin]
|
Watson Pharmaceuticals Appoints Christopher W. Bodine to Board of Directors
HSMN NewsFeed,
29 Jun 2009:
Biopharmaceuticals, Personnel
[Watson Pharmaceuticals]
|
Wake Pharm US Announces Appointment of Jeffrey A. Niezgoda, M.D. to the Board of Medical Advisors
HSMN NewsFeed,
29 Jun 2009:
Biopharmaceuticals, Wound Care, Personnel
[Wake Pharm US]
|
Dermatologic and Ophthalmic Drugs Advisory Committee Unanimously Recommends Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
HSMN NewsFeed,
26 Jun 2009:
Biopharmaceuticals, Ophthalmology
[ISTA Pharmaceuticals, Bepreve, bepotastine]
|
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
HSMN NewsFeed,
26 Jun 2009:
Biopharmaceuticals, Regulatory
[Schering-Plough, Centocor Ortho Biotech, SIMPONI, golimumab]
|
AZZALURE(R) Approved in Germany for Aesthetic Use in the Treatment of Glabellar Lines
HSMN NewsFeed,
26 Jun 2009:
Biopharmaceuticals, Dermatology, Regulatory
[Ipsen, Galderma, Azzalure, botulinum toxin Type A, glabellar lines]
|
|
|
Public
Feeds 
Full text >>